NSG BioLabs and Eppendorf Collaborate to Boost Biotech Innovation

Web DeskJune 13, 2024 02:09 PMbusiness
  • Exclusive access to cutting-edge equipment and services for biotech startups
  • NSG BioLabs supports over 40 companies with state-of-the-art facilities
  • Partnership aims to drive groundbreaking discoveries in life sciences
NSG BioLabs and Eppendorf Collaborate to Boost Biotech InnovationImage Credits: en_prnasisa
NSG BioLabs and Eppendorf have teamed up to provide biotech startups in Singapore with exclusive access to cutting-edge equipment and services, aiming to drive groundbreaking discoveries in the field of life sciences. With state-of-the-art facilities and a focus on innovation, this collaboration is set to shape the future of biotech innovation.

NSG BioLabs, the leading biotech co-working laboratory and office space provider in Singapore, has joined forces with Eppendorf, a renowned international life science company, to empower biotech startups in their research and development endeavors. This collaboration aims to offer valuable resources such as product expertise, applications support, and networking opportunities to drive innovation in the biotech sector.

Since its establishment in 2019, NSG BioLabs has been a pivotal player in supporting innovators across various industries including health, biomedical, agrifood, and industrial biotechnology. Their focus areas encompass precision medicine, nucleic acids, AI-enabled drug discovery, and synthetic biology. With the largest biotech laboratory and office space in Singapore, NSG BioLabs has already assisted over 40 companies, ranging from multinationals to promising startups.

The partnership with Eppendorf will grant NSG BioLabs residents exclusive access to cutting-edge equipment, consumables, and services, enabling them to expedite their research processes and scale their innovations. This collaboration is poised to foster groundbreaking discoveries in the realm of life sciences and drive the future of medical innovation.

NSG BioLabs offers BSL-2 certified private and shared laboratory spaces, fully-equipped offices, a wide array of equipment, and connections to service providers and suppliers. With a total of three sites spanning 35,000 square feet within Singapore's vibrant R&D ecosystem, NSG BioLabs stands as a central hub for biotech innovation in the region.

Eppendorf, dedicated to enhancing human living conditions, specializes in developing and distributing instruments, consumables, and services for laboratories worldwide. Their products cater to diverse industries and research fields, including pharmaceuticals, biotech, and clinical laboratories.

Founded with a mission to bolster biotech innovation, NSG BioLabs provides state-of-the-art equipment, streamlined operations, and global networks to support life sciences companies. By furnishing top-notch infrastructure, strategic partnerships, and added benefits, NSG BioLabs empowers companies to efficiently carry out cutting-edge research and development projects, ultimately leading to the creation of revolutionary technologies and products in the biotech domain.

The partnership between NSG BioLabs and Eppendorf signifies a significant step towards fostering innovation and driving progress in the biotech industry. By combining their expertise and resources, these two entities are poised to catalyze impactful discoveries and shape the future landscape of medical innovation. Through this collaboration, biotech startups in Singapore are set to receive unparalleled support and opportunities for growth, paving the way for transformative advancements in the field of life sciences.

Related Post